AtaiBeckley (ATAI) Net Margin (2021 - 2026)
AtaiBeckley's (ATAI) quarterly Net Margin came in at 3121.8% in Q1 2026, down 142206.0% year-on-year from N/an in Q1 2025, and down 83.66% quarter-over-quarter from 1699.74% in Q1 2025.
AtaiBeckley (ATAI) Net Margin (2021 - 2026) Analysis & Trends
AtaiBeckley (ATAI) has 5 years of Net Margin data on file, last reported at 8154.07% in Q3 2025.
- For the quarter ending Q3 2025, Net Margin rose 5756093.0% year-over-year to 8154.07%; the trailing twelve-month figure through Sep 2025 stood at 5081.55% (up 3390909.0% YoY), and the FY2024 full-year result was 48067.86%, down 3523283.0% from the prior year.
- Net Margin eased to 3121.8% in Q1 2026 per ATAI's latest filing, from 1699.74% in the prior quarter.
- Across five years, Net Margin topped out at 1699.74% in Q1 2025 and bottomed at 3121.8% in Q1 2026.
- A 5-year average of 55578.23% and a median of 21213.23% in 2021 frame the typical range for Net Margin.
- Across the five-year window, Net Margin jumped 19205101 bps in 2023 and plunged 22076944 bps in 2024, its largest moves.
- Tracing ATAI's Net Margin over 5 years: stood at 21433.04% in 2021, then plunged by 395 bps to 105989.47% in 2022, then grew by 2 bps to 104155.56% in 2023, then tumbled by 212 bps to 324925.0% in 2024, then soared by 97 bps to 8154.07% in 2025.
- Business Quant data shows ATAI's Net Margin at 8154.07% in Q3 2025, 3856.61% in Q2 2025, and 1699.74% in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Net Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 15.02% |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 34.53% |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 20.17% |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | 30.33% |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | - |
| 10 | AtaiBeckley | 2.56 Bn | 2.56 Bn | - | -8,154.07% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -3,121.80% |
| Sep 30, 2025 | -8,154.07% |
| Jun 30, 2025 | -3,856.61% |
| Mar 31, 2025 | -1,699.74% |
| Mar 31, 2025 | -1,699.74% |
| Dec 31, 2024 | -324,925.00% |
| Sep 30, 2024 | -65,715.00% |
| Jun 30, 2024 | -20,993.41% |
| Dec 31, 2023 | -104,155.56% |
| Sep 30, 2023 | 50,855.17% |
| Jun 30, 2023 | -19,210.47% |
| Mar 31, 2023 | -89,554.05% |
| Dec 31, 2022 | -105,989.47% |
| Sep 30, 2022 | -141,195.83% |
| Jun 30, 2022 | -21,540.00% |
| Dec 31, 2021 | -21,433.04% |
| Sep 30, 2021 | -11,713.53% |
| Mar 31, 2021 | 28.91% |